amplification Search Results


elast elisa amplification system  (Revvity)
92
Revvity elast elisa amplification system
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Elast Elisa Amplification System, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elast elisa amplification system/product/Revvity
Average 92 stars, based on 1 article reviews
elast elisa amplification system - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
atailing kit  (TaKaRa)
99
TaKaRa atailing kit
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Atailing Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atailing kit/product/TaKaRa
Average 99 stars, based on 1 article reviews
atailing kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
1x isothermal amplification buffer  (New England Biolabs)
96
New England Biolabs 1x isothermal amplification buffer
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
1x Isothermal Amplification Buffer, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1x isothermal amplification buffer/product/New England Biolabs
Average 96 stars, based on 1 article reviews
1x isothermal amplification buffer - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
reaction mixture  (New England Biolabs)
96
New England Biolabs reaction mixture
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Reaction Mixture, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reaction mixture/product/New England Biolabs
Average 96 stars, based on 1 article reviews
reaction mixture - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
nebnext single cell  (New England Biolabs)
96
New England Biolabs nebnext single cell
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Nebnext Single Cell, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nebnext single cell/product/New England Biolabs
Average 96 stars, based on 1 article reviews
nebnext single cell - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
1x plus automation 12 amplification diluent  (Akoya Biosciences)
95
Akoya Biosciences 1x plus automation 12 amplification diluent
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
1x Plus Automation 12 Amplification Diluent, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1x plus automation 12 amplification diluent/product/Akoya Biosciences
Average 95 stars, based on 1 article reviews
1x plus automation 12 amplification diluent - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cellamp whole transcriptome amplification kit  (TaKaRa)
93
TaKaRa cellamp whole transcriptome amplification kit
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Cellamp Whole Transcriptome Amplification Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellamp whole transcriptome amplification kit/product/TaKaRa
Average 93 stars, based on 1 article reviews
cellamp whole transcriptome amplification kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
marathon cdna amplification kit  (TaKaRa)
99
TaKaRa marathon cdna amplification kit
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Marathon Cdna Amplification Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/marathon cdna amplification kit/product/TaKaRa
Average 99 stars, based on 1 article reviews
marathon cdna amplification kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
illustra genomiphi dna amplification v2 kit  (GE Healthcare)
94
GE Healthcare illustra genomiphi dna amplification v2 kit
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Illustra Genomiphi Dna Amplification V2 Kit, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illustra genomiphi dna amplification v2 kit/product/GE Healthcare
Average 94 stars, based on 1 article reviews
illustra genomiphi dna amplification v2 kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
illustra templiphi amplification kit  (GE Healthcare)
93
GE Healthcare illustra templiphi amplification kit
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
Illustra Templiphi Amplification Kit, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illustra templiphi amplification kit/product/GE Healthcare
Average 93 stars, based on 1 article reviews
illustra templiphi amplification kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
10 × isothermal amplification buffer ii pack  (New England Biolabs)
94
New England Biolabs 10 × isothermal amplification buffer ii pack
A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by <t>ELISA.</t> Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.
10 × Isothermal Amplification Buffer Ii Pack, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10 × isothermal amplification buffer ii pack/product/New England Biolabs
Average 94 stars, based on 1 article reviews
10 × isothermal amplification buffer ii pack - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by ELISA. Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.

Journal: PLoS ONE

Article Title: Near-Infrared Laser Adjuvant for Influenza Vaccine

doi: 10.1371/journal.pone.0082899

Figure Lengend Snippet: A, Serum ovalbumin- (OVA)-specific IgG titers 3, 6, and 12 weeks following vaccination with 40 µg OVA with or without laser illumination. Endpoint titer of OVA-specific serum IgG was determined by ELISA. Plates were coated with OVA. n = 33, 19, 15, 12 and 11, 5 and 6, 6 and 6 for no OVA, OVA i.d., OVA +Alum i.d., OVA i.d. + PW 532 nm 1 and 4 minutes, OVA i.d. + PW 1064 nm 1 and 4 minutes, OVA i.d. + CW 1064 nm 1 and 4 minutes, respectively. Error bars show means ± s.e.m. * P <0.05, ** P <0.01 and *** P <0.001 as compared to OVA i.d. B, The relationships between anti-OVA antibody titers following 1–4 minutes PW 532 nm, PW 1064 nm and CW 1064 nm laser-treated groups at 6 weeks (logIgG) and maximal skin surface temperature (Tm) was not statistically significant; a Pearson's correlation coefficient r = −0.237 ( P = 0.08), where log(IgG) = −0.193Tm+10.75 (linear regression, R 2 = 0.056). n = 20, 17, 18, for OVA i.d. + PW 532 nm 1–4 minutes, OVA i.d. + PW 1064 nm 1–4 minutes, OVA i.d. + CW 1064 nm 1–4 minutes.

Article Snippet: In the case of IgE, the wells were further treated with ELAST ELISA Amplification System (Perkin Elmer) to improve sensitivity of the assay.

Techniques: Enzyme-linked Immunosorbent Assay

A–G, Influenza-specific IgG subclass titers (A–C) in pre-challenge serum (4 weeks after vaccination) and (D–G) post-challenge (4 days after challenge). Mice were vaccinated with 1 µg of inactivated influenza virus (A/PR/8/34) with or without laser illumination or the licensed chemical adjuvant (alum) and challenged intranasally with live homologous virus 4 weeks after vaccination. Titer of influenza-specific serum IgG subclass was determined by ELISA. Plates were coated with inactivated influenza virus. (A and D) IgG, (B and E) IgG1, (C and F) IgG2c, and (G) IgE titers. Experimental and control groups: (A–C) n = 38, 47, 25, 50, 12 (D–F) n = 25, 29, 12, 32, 12 (G) n = 24, 21, 13, 24, 12 for no vaccine, vaccine i.d., vaccine i.d. + PW 532 nm, vaccine i.d. + CW 1064 nm, and vaccine + Alum i.d. vaccine groups, respectively.

Journal: PLoS ONE

Article Title: Near-Infrared Laser Adjuvant for Influenza Vaccine

doi: 10.1371/journal.pone.0082899

Figure Lengend Snippet: A–G, Influenza-specific IgG subclass titers (A–C) in pre-challenge serum (4 weeks after vaccination) and (D–G) post-challenge (4 days after challenge). Mice were vaccinated with 1 µg of inactivated influenza virus (A/PR/8/34) with or without laser illumination or the licensed chemical adjuvant (alum) and challenged intranasally with live homologous virus 4 weeks after vaccination. Titer of influenza-specific serum IgG subclass was determined by ELISA. Plates were coated with inactivated influenza virus. (A and D) IgG, (B and E) IgG1, (C and F) IgG2c, and (G) IgE titers. Experimental and control groups: (A–C) n = 38, 47, 25, 50, 12 (D–F) n = 25, 29, 12, 32, 12 (G) n = 24, 21, 13, 24, 12 for no vaccine, vaccine i.d., vaccine i.d. + PW 532 nm, vaccine i.d. + CW 1064 nm, and vaccine + Alum i.d. vaccine groups, respectively.

Article Snippet: In the case of IgE, the wells were further treated with ELAST ELISA Amplification System (Perkin Elmer) to improve sensitivity of the assay.

Techniques: Virus, Adjuvant, Enzyme-linked Immunosorbent Assay, Control